Gabapentin to Improve Patient Tolerance in Endoscopic Retrograde Cholangiopancreatography (ERCP)
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The standard approach to sedation in endoscopic retrograde cholangiopancreatography (ERCP)
involves the use of benzodiazepines and opiates to achieve a moderate depth of sedation.
There is data to suggest supplementing this regimen with gabapentin may lead to reduced pain,
higher patient satisfaction and lower opiate requirements. The investigators are conducting a
clinical trial to study this hypothesis.